Showing results (361-370 of 465) with videos related to
Sort By:
Pageof 47
Oncotarget|March 27, 2025
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMTLanlan Zhou, Leiqing Zhang, Jun Zhang, et al.Biorxiv : the Preprint Server for Biology|August 6, 2025
Enabling CAR-T Cell Immunotherapy in Glioblastoma by Modifying Tumor Microenvironment via Oncolytic Adenovirus Encoding Bispecific T Cell EngagerMoon Jung Choi, Eui Young So, Bedia Akosman, et al.Interventional Pain Medicine|November 6, 2024
FACTFINDERS FOR PATIENT SAFETY: Minimizing risks with cervical epidural injectionsEric K Holder, Haewon Lee, Aditya Raghunandan, et al.Neurosurgery|September 17, 2016
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Preoperative Imaging Assessment of Patients With Suspected Nonfunctioning Pituitary AdenomasClark C Chen, Bob S Carter, Renzhi Wang, et al.Archives of Dermatology|December 23, 2009
Incidence of and risk factors for skin cancer after heart transplantJerry D Brewer, Oscar R Colegio, P Kim Phillips, et al.Immunotherapy|February 10, 2018
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?Maureen L Aliru, Jonathan E Schoenhals, Bhanu P Venkatesulu, et al.Journal of Plastic Surgery and Hand Surgery|May 25, 2021
A 28-year single institution experience with primary skin malignancies in the pediatric populationDoga Kuruoglu, Jason M Weissler, Samyd S Bustos, et al.Journal of the American Academy of Dermatology|December 4, 2012
Prognostic factors in Merkel cell carcinoma: analysis of 240 casesTina I Tarantola, Laura A Vallow, Michele Y Halyard, et al.Oncotarget|October 4, 2014
Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomasJie Li, Zachary J Taich, Amit Goyal, et al.Oncotarget|October 28, 2015
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registryPei Yang, Wei Zhang, Yinyan Wang, et al.Pageof 47